Madrigal Pharmaceuticals, Inc. (MDGL)
435.91
+10.06
(+2.36%)
USD |
NASDAQ |
Mar 04, 16:00
440.00
+4.09
(+0.94%)
After-Hours: 20:00
Madrigal Pharmaceuticals Cash from Investing (TTM) : 32.32M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Insmed, Inc. | -64.58M |
| Pfizer Inc. | -1.351B |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Eli Lilly & Co. | -10.97B |
| Johnson & Johnson | -23.59B |